Sepsis Trial Update Sending Shares of this Medical Device Maker Higher
01 Agosto 2024 - 8:20PM
AllPennyStocks.com
This Phase 3 company is seeking U.S. FDA approval for its unique
product for the treatment of patients with septic shock, and shares
are moving up.
Late-stage theranostic company Spectral...
To read the full story on AllPennyStocks.com, click
here.
Grafico Azioni Spectral Medical (TSX:EDT)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Spectral Medical (TSX:EDT)
Storico
Da Feb 2024 a Feb 2025